glp 1 agonist small molecule Figure from Drug Discovery at the Glucagon-Like Peptide-1 Receptor Current Insights, Advantages and Challenges
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Campbell JE, et al
13% of adults aged 30 to 49 have used GLP-1 medications, including 6% saying they used them for weight loss, 3% to treat a chronic condition, and 1% for both
29 The mean eGFR was 61 ml/min/1.73 m
Builds on prior excellent data from injectables in OSA
The trials indicated that all doses of tirzepatide resulted in greater weight loss and enhanced glycemic control in comparison to placebo
